Table 2.
Population, selected risk factors and mortality for non-communicable disease in China and Italy, as relevant for severe acute respiratory syndrome coronavirus 2–related disease (COVID-19).
| China | Italy | Source | |
|---|---|---|---|
| Population size (2020), thousands | 1,439,324 | 60,462 | UN |
| Male/female, ratio | 1.05 | 0.95 | UN |
| Median age, years | |||
| Total | 37.4 | 45.5 | UN |
| Male | 36.5 | 44.4 | |
| Female | 38.4 | 46.5 | |
| People aged >65 years, % | 25.3 | 65.2 | UN |
| Prevalence of tobacco smokers, % | Male: 45.7 | Male: 26.9 | WHO |
| Female: 1.4 | Female: 19.6 | ||
| Mortality for the principal NCDs, % | |||
| CVD | 43 | 36 | WHO |
| Cancer | 23 | 27 | |
| COPD | 9 | 6 | |
| Diabetes | 2 | 3 | |
| Cancer incidence, age-standardised rates per 100,000 | 201.7 | 290.6 | Globocan 2018 |
| Cancer mortality, age-standardised rates per 100,000 | 130.1 | 94.1 | Globocan 2018 |
| Patients with cancer among patients with COVID-19, % | 9 of 18 patients with cancer had severe events or died (0.5% of the COVID-19 cases) |
150 patients with cancer/909 deaths from COVID-19 (16.5% of all COVID-19 deaths) |
China: Liang et al.[8] (Lancet Oncology, 2020) Italy: ISS, 30th March 2020 |
COPD, chronic obstructive pulmonary disease; CVD, cardiovascular disease; ISS, Istituto Superiore di Sanità; NCDs, non-communicable diseases; WHO, World Health Organization; UN, United Nations; COVID-19, coronavirus disease 2019.